Use access key #2 to skip to page content.
$39.02 -3.29 (-7.78%)
12/1/2008 4:00 PM

Biogen Idec, Inc. (BIIB)

CAPS Rating:
****

The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies.

View All Commentary (BIIB)

Recs

0

Avatar chrisccarlson (73.36) Submitted: 11/03/06 10:13 PM : Outperform Start Price: $48.01 BIIB Score: 21.63

If you like biotech this is your bluechip

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links